Company profile

Pramana

Pathology & Laboratory Diagnostics

Company profile

About Pramana

Pramana is a digital pathology company that has developed what it calls Digital Pathology 2.0 - a generational advancement in whole slide imaging technology. The company's flagship products are the Spectral family of scanners, which feature autonomous operation capable of handling most slide types without user intervention, including challenging specimens. Pramana's innovative approach separates slide handling mechanisms from scan heads, offering modular and scalable solutions that allow labs to customize their setup and quickly upgrade capacity as needs grow. The technology is built on a pioneering volumetric imaging method that replicates the fine-focus function of optical microscopes, backed by a portfolio of granted U.S. patents. Key differentiators include built-in inline quality assurance with fully autonomous rescanning, edge AI capability to execute multiple feature description algorithms in real time during scanning, and compatibility with diverse specimen types including tissue biopsies, cytology samples, bone marrow, microbiology slides, and wet mounts. The company addresses critical pain points in traditional digital pathology including high manual quality control burden, underutilized scanner capacity, and slow cloud-based image analysis. In August 2024, Pramana was acquired by Evident (formerly Olympus Scientific Solutions), expanding Evident's digital pathology portfolio. The company's solutions are designed for anatomic pathology, cytopathology, hematopathology, clinical pathology, and microbiology applications, serving healthcare organizations and research institutions globally.

Company description Pramana official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Pramana?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Anatomic pathology
  • Clinical Pathology
  • Cytopathology
  • Hematopathology
  • Microbiology

Who it serves

  • Cancer Centers
  • Clinical Pathology Labs
  • Health Systems
  • Research Institutions

Deployment & integration

On Premise deployment with recorded integration context.

Recorded integration context: IMS Vendors, Siemens Healthineers.

Geographic context

MarketsCanada · Germany · United States
Company sourceOfficial website

Company milestones

Platform expansion

Acquired by Evident in August 2024; Health Canada authorization for SpectralM and SpectralHT Cubiq scanners in July 2024; Moffitt Cancer Center deployment in October 2024; Siemens Healthineers collaboration at Klinikum Ludwigshafen in September 2024

Partnerships

Recorded partners

  • Evident (parent company - acquired August 2024)
  • Klinikum Ludwigshafen
  • Moffitt Cancer Center
  • Siemens Healthineers

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Spectral Cubiq

Autonomous whole slide imaging system with inline quality assurance

Device · On PremiseCompany source

SpectralHT

High-throughput autonomous whole slide imaging scanner with modular, scalable design

Device · On PremiseCompany source

SpectralM

Modular digital pathology scanner for smaller slide volumes and specialized applications

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Autonomous operation handling most slide types without user intervention

Reduces manual quality control burden

6-7 hours average scan time for 480 slide load

High-throughput scanning efficiency

Real-time algorithm execution during scanning

Results instantly available upon scan completion

Moffitt Cancer Center

Expand digital pathology adoption to support clinical and research initiatives using high-throughput scanning technology

Klinikum Ludwigshafen

Advance digital pathology through collaboration combining AI imaging, diagnostics expertise, and clinical leadership with Siemens Healthineers partnership

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Pramana

Recent articles published on Pramana's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon